智通财经APP获悉，GSK(GSK.US)日前宣布，美国FDA已授予其PD-1抑制剂Jemperli(dostarlimab)用于治疗局部晚期错配修复缺陷(dMMR)/高微卫星不稳定性(MSI-H)直肠癌的突破性疗法认定(BTD)。这是dostarl ...

▎药明康德内容团队编辑GSK日前宣布，美国FDA已授予其PD-1抑制剂Jemperli（dostarlimab）用于治疗局部晚期错配修复缺陷（dMMR）/高微卫星不稳定性（MSI-H）直肠癌的突破性疗法认定（BTD）。根据新闻稿，这是dostarli ...

Shutdown Grows Closer as Trump Tells G.O.P. to Kill Spending Deal The bill Republicans and Democrats agreed on is in jeopardy after President-elect Trump condemned it three days before the ...

Things became litigious in 2017, when a Delaware court found that Teva's label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK's RE40,000 ...

On Thursday Greece is set to return to Turkey 1,055 ancient Lydian coins, seized by the Greek authorities, a move that highlights the increased cooperation between the two countries in fighting ...

A sign displays the crest and name of the London Stock Exchange in London, Britain August 15, 2017. REUTERS/Neil Hall/File Photo UK's main FTSE 100 stock index dropped 1% and revisited its near ...